Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure

Heart

Volumn 90, Issue 6, 2004, Pages 655-660

  Viotti, R J ^a,b,c   Vigliano, C ^b   Laucella, S ^b   Lococo, B ^b   Petti, M ^b   Bertocchi, G ^b   Ruiz Vera, B ^b   Armenti, H ^b  

^a Hospital Eva Perón ^*  (Argentina)

^b Hospital Eva Peron   (Argentina)

^c Clinica Bessone   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ADULT; ARTICLE; CHAGAS DISEASE; CHRONIC DISEASE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; ECG ABNORMALITY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM ENLARGEMENT; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE OVERLOAD; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SEROLOGY; THORAX RADIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 2442717536     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.018960     Document Type: Article

References (30)

1. Feldman AM, Mac Namara D. Myocarditis. N Engl J Med 2000;343:1388-98.
2. Anon. Tropical disease research progress 1975-1994 highlights 1993-1994. Twelfth programme report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). Geneva: World Health Organization, 1995:125-34.
3. Elizari M. La miocardiopatía chagásica: perspectiva histórica. Medicina 1999;59(suppl II):25-40.
4. Yoshida N, Schenkman S. American trypanosomiasis. Curr Opin Infect Dis 1997;10:351-6.
5. Jones EM, Colley DG, Tostes S, et al. Amplification of a Trypanosoma cruzi DNA sequence of inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg 1993;48:348-57.
6. Brandariz S, Schijman A, Vigliano C, et al. Detection of parasite DNA in Chagas' heart disease. Lancet 1995;346:1370.
7. Ouaissi A, Da Silva A, Guevara A, et al. Trypanosoma cruzi-induced host immune system dysfunction: a rationale for parasite immunosuppressive factor(s) encoding gene targeting. J Biomed Biotechnol 2001;1:11-7.
8. Tarleton RL, Zhang L. Chagas disease etiology: autoimmunity or parasite persistence? Parasitol Today 1999;15:94-9.
9. Andrade ZA. Immunopathology of Chagas disease. Mem Inst Oswaldo Cruzi 1999;94(suppl I):71-80.
10. Laranja F, Dias E, Nobrega G, et al. Chagas disease: a clinical, epidemiologic and pathologic study. Circulation 1956;14:1035-60.
11. Puigbó J, Giordano H, Suárez C, et al. Aspectos clínicos en la enfermedad de Chagas. In: Madoery R, Madoery C, Cámera M, eds. Actualizaciones en la enfermedad de Chagas. Simposio satélite. Organismo oficial del Congreso Nacional de Medicina. 1993:27-38.
12. Manzullo EC, Chuit R. Risk of death due to chronic chagasic cardiopathy. Mem Inst Oswaldo Cruz 1999;94(suppl 1):317-20.
13. Storino R. Chagas crónico. In: Storino R, Milei J, eds. Enfermedad de Chagas. Buenos Aires: Mosby, 1994:249-54.
14. Espinosa R, Carrasco HA, Belandria F, et al. Life expectancy analysis in patients with Chagas disease: prognosis after one decade. Int J Cardiol 1985;8:45-56.
15. Espinosa RA, Pericchi LR, Carrasco HA, et al. Prognostic indicators of chronic chagasic cardiopathy. Int J Cardiol 1991;30:195-202.
16. Bestetti RB, Dalbo CM, Freitas OC, et al. Non-invasive predictors of mortality for patients with Chagas heart disease: a multivariate stepwise logistic regression study. Cardiology 1994;84:261-7.
17. Rodriguez-Salas LA, Klein E, Acquatella H, et al. Echocardiographic and clinical predictors of mortality in chronic Chagas' disease. Echocardiography 1998;15:271-8.
18. De Almeida Filho OC, Maciel BC, Schmidt A, et al. Minor segmental dyssynergy reflects extensive myocardial damage and global left ventricle dysfunction in chronic Chagas disease. J Am Soc Echocardiogr 2002;15:602-16.
19. Barras MV, Rocha MO, Ribeiro AL, et al. Doppler tissue imaging to evaluate early myocardium damage in patients with undetermined form of Chagas' disease and normal echocardiogram. Echocardiography 2001;18:131-6.
20. Salomone OA, Caeiro T. Regional changes of ventricular motility in patients with positive serology for Chagas disease. Medicina 1996;56:690-8.
21. Viotti R, Vigliano C, Armenti H, et al. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am Heart J 1994;127:151-62.
22. Kuschnir E, Sgammini H, Castro R, et al. Valoración de la función cardíaca por angiografía radioisotópica, en pacientes con cardiopatía chagásica crónica. Arq Bras Cardiol 1985;45:249-56.
23. Feigenbaum H. Echocardiographic evaluation of cardiac chambers. In: Feigenbaum H, ed. Echocardiography, 5th edn. Philadelphia: Lea & Febiger, 1994:147-9.
24. Bestetti RB. Role of apical aneurysm on the prognosis of chronic Chagas disease. Am J Cardiol 1998;82:1561.
25. Modena MG, Muia N, Sgura FA, et al. Left atrial size is the major predictor of cardiac death and overall clinical outcome in patients with dilated cardiomyopathy: a long-term follow-up study. Clin Cardiol 1997;20:553-60.
26. Higuchi ML, De Morais CF, Pereira Barreto AC, et al. The role of active myocarditis in the development of heart failure in chronic Chagas' disease: a study based on endomyocardial biopsies. Clin Cardiol 1987;10:665-70.
27. Elizari MV, Chiale PA. Cardiac arrhythmias in Chagas heart disease. J Cardiovasc Electrophysiol 1993;4:596-608.
28. Acquatella H, Schiller N, Puigbo J, et al. M-mode and two dimensional echocardiography in chronic Chagas heart disease: a clinical and pathologic study. Circulation 1980;62:787-99.
29. Medina N, Carrasco H, Fuenmayor A, et al. Diagnosis by non-invasive methods of incipient left ventricular lesions in patients with Chagas' disease. Use of echocardiographic and mechanocardiography. Arch Inst Cardiol Mex 1980;50:663-9.
30. Rigou DG, Gullone N, Carnevali L, et al. Asymptomatic Chagas disease: electrocardiographic and echocardiographic findings. Medicina 2001;61:541-4.